+91-98 455 710 46 | info@nckpharma.com

Please sign in first

Username

Password

Lost Your Password?

Not a member?

Please simply create an account before buying/booking any courses.

Create an account for free!

Home
About Us
- Group of Companies
- Subscribe to free learning
NCK services
Course List
Admission
Contact

Home
About Us
- Group of Companies
- Subscribe to free learning
NCK services
Course List
Admission
Contact

Tag

Elezanumab

AbbVie’s Elezanumab receives US FDA orphan drug and fast track designations

Posted on30 Sep 2020

TagsAbbVie, Elezanumab, Fast Track designation, MAB, monoclonal antibody, orphan drug

Comments0

AbbVie announced that the US Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an...

Our Popular Courses

Pharma Product Management
Digital Pharma Marketing
Strategic Management
Regulatory Affairs
Pharma Marketing
European DRA
Sales Management
Pharmacovigilance
Production Management
ASEAN DRA
GCC DRA
Pharma Project Management
Export Documentation

Recent Articles

Case Insight – Torrent Pharma to acquire dermatology company Curatio Health Care
Pfizer to acquire Biohaven Pharma for $11.6 billion
EMA recommendation for 2022-2023 seasonal flu vaccine composition
Aurobindo Pharma acquires Veritaz Healthcare
Sun Pharma to launch Vortioxetine in India
what is meaning of clinically significant endpoint?
US FDA grants Breakthrough Therapy Designation for Pfizer’s RSVpreF
Is HEOR and Market Access is same?
Symbicort 1st generic Approval by USFDA
Case Study : Vimpat patent expired on 17th of March, 2022 and generic entry
Case Study : US FDA approval of Marinus Pharma’s Ztalmy
Lynk Pharma, Simcere licensing deal for development of novel JAK1 inhibitor LNK01001 in China
What if Design of experiments (DoE) approach?
Torrent Pharma to manufacture and sell Pfizer’s Paxlovid generic
What are the application of IVIVC?
What is the meaning of IVIVC?
Insight on AstraZeneca’s global R&D Postdoctoral Challenge initiative
Medtronic launched MiniMed 780G system to manage type 1 diabetes
Case Study: Pfizer’s Arena acquisition – A $6.7B deal
Market Access – Check your competency

Course Category

KPE® – Certificate Program (1 Month)
KPE® – Certificate Program (1 Week)
KPE® – Publications / White Papers / Workshop / Others
KPE® Advance Diploma Program (1 Year Program)
KPE® Advance Diploma Program – Dual Specialization (1 Year Program)
KPE® Executive Program (1 Year Program)

NCK Pharma Solution Private Limited which is conceptualized in Year 2009 with a vision to spearhead innovation in the field of Pharmaceutical, Biotechnology, Medical Devices learning with the technological advances. The mission is to provide "Best On The Go" training services across those industries To Create, Develop, Train tomorrows Industry leaders.

GST No. 07AADCN2088D1ZM
PAN NO. AADCN2088D
CIN/ Foreign Company Registration Number: u74900dl2009ptc191741

Important URLs

Admission Process
Frequently asked question related to KPE courses
Prospect Identification Process
Verify Course Certificate
Request for Course Completion Certificate

Contact us

General Enquiry / Doubt clarification : info@nckpharma.com

Human Resource : HR@testnckpharma.com

To Escalate any issues: saikatroy@nckpharma.com

Javascript is disabled

Javascript is disabled on your browser. Please enable it in order to use this form.

Loading

Query

First Name

Last Name

Email Address

Your Query *

Write Here

5 plus 10 equals?*

Prove you are a human

Write here

Your form has been submitted

Thank you %NAME% for the submitting your query/feedback.

Server Side Error

We faced problems while connecting to the server or receiving data from the server. Please wait for a few seconds and try again.

If the problem persists, then check your internet connectivity. If all other sites open fine, then please contact the administrator of this website with the following information.

TextStatus: undefined
HTTP Error: undefined

Processing your request

Error

Some error has occured.

Disclaimer & Privacy Policy | Terms of Use

Copyright © 2022-2032 All Right Reserved - NCK Pharma Solution Private Limited

This website uses cookies to improve your learning experience. Ok Privacy Policy

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests

etc.